Hooshfar Shirin, Bartlett Michael G
Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, The University of Georgia, Athens, GA, USA.
Biomed Chromatogr. 2017 Jan;31(1). doi: 10.1002/bmc.3859. Epub 2016 Nov 6.
Bioanalytical methods are employed for the quantitative determination of drugs and their metabolites in biological matrices, in all stages of the drug development process. However, because of the highly complex nature of these matrices there is a wide range of potential biological, chemical and physical hazards that can influence the quality of the data produced by these methods. The present review focuses on the evaluation of the most important and frequent errors that may be encountered during bioanalytical method development/validation and analysis of clinical or preclinical samples mainly using chromatography. Additionally, the most practical ways for avoiding and managing these hazards during routine bioanalysis are presented.
生物分析方法用于在药物研发过程的各个阶段对生物基质中的药物及其代谢物进行定量测定。然而,由于这些基质具有高度复杂性,存在广泛的潜在生物、化学和物理危害,可能会影响这些方法所产生数据的质量。本综述重点评估在生物分析方法开发/验证以及临床或临床前样品分析(主要使用色谱法)过程中可能遇到的最重要且最常见的误差。此外,还介绍了在常规生物分析过程中避免和管理这些危害的最实用方法。